CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy
Clinical trial NCT03356912 · UNKNOWN
Trial details
- NCT number
- NCT03356912
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-22
- Primary completion
- 2021-05-04
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.